| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 12.465 | 3.875 | 18.748 | 33.236 | 25.097 | 20.611 | 26.564 | 9.242 | 5.648 | 3.765 |
| Total Income - EUR | 12.465 | 3.875 | 18.748 | 33.236 | 25.098 | 20.611 | 26.564 | 9.242 | 5.648 | 3.765 |
| Total Expenses - EUR | 3.280 | 3.250 | 5.820 | 6.482 | 4.062 | 3.365 | 4.588 | 2.808 | 3.329 | 3.543 |
| Gross Profit/Loss - EUR | 9.185 | 625 | 12.927 | 26.754 | 21.035 | 17.246 | 21.975 | 6.435 | 2.319 | 222 |
| Net Profit/Loss - EUR | 8.811 | 508 | 12.365 | 25.757 | 20.282 | 16.628 | 21.195 | 6.158 | 1.932 | 157 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Neotoxic S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 265 | 52 | 0 | 0 | 593 | 879 | 477 | 995 | 491 | 1.298 |
| Current Assets | 13.779 | 1.060 | 14.634 | 31.050 | 22.330 | 19.935 | 26.109 | 6.015 | 2.516 | 2.460 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 3 | 132 | 6.078 | 6 | 10.600 | 0 | 17.675 | 5.148 | 407 | 2.428 |
| Cash | 13.776 | 928 | 8.557 | 31.043 | 11.730 | 19.935 | 8.435 | 867 | 2.109 | 31 |
| Shareholders Funds | 11.874 | 553 | 12.409 | 25.800 | 20.324 | 16.669 | 21.235 | 6.198 | 3.007 | 3.147 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 2.170 | 560 | 2.226 | 5.250 | 2.599 | 4.145 | 5.351 | 812 | 0 | 612 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4642 - 4642" | |||||||||
| CAEN Financial Year |
4619
|
|||||||||
Comments - Neotoxic S.r.l.